Skip to content
Trial Eligibility
Menu

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

NCT05995821

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This research is being done to collect and store biological specimens (biospecimens) from people with cancer, regardless of tumor type, who are receiving treatments known or thought to have an effect on the immune system. The goal of this discovery and exploratory study is to: Understand changes in the immune system associated with various cancer treatments, in order to better design new therapies or tests to predict how these treatments might work. Identify risk factors for those who go on to develop side effects from immunotherapy.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Head and Neck Cancer
  • Lung Cancer
  • Gastrointestinal Cancer

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Last updated on ClinicalTrials.gov
August 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • Johns Hopkins University · Baltimore, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.